Search - tctmd.com

Displaying 381 - 400 of 571

Sort: Relevancy | Date

News Conference News EuroPCR 2019

Clip-Based Tricuspid Repair Improves Regurgitation, Function, and Quality of Life: TRILUMINATE

Michael O'Riordan

May 22, 2019

News Conference News EuroPCR 2019

MR Reduction Linked to Lower HF Hospitalizations and Deaths, Regardless of Intervention: COAPT

Shelley Wood

May 21, 2019

News Daily News

PFO Compounds Ischemic Stroke Risk Among Patients With Pulmonary Embolism

Yael L. Maxwell

May 06, 2019

News Industry News

Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer™

May 06, 2019

News Daily News

Public Comments Largely Supportive of CMS Plan for TAVR, With Some Suggested Tweaks

Todd Neale

May 01, 2019

News Industry News

Medtronic Receives FDA Approval for World's First Quadripolar Active Fixation Left Heart Lead

May 01, 2019

News Daily News

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

L.A. McKeown

April 19, 2019

News Daily News

Cardioband Reduces Severe Tricuspid Regurgitation at 6 Months, With Good Safety: TRI-REPAIR

Yael L. Maxwell

April 17, 2019

News Industry News

Neovasc Announces Peer Reviewed Publication in the International Journal of Cardiology Demonstrating that the Neovasc Reducer™ Improves Diastolic Function in patients suffering from severe angina

April 17, 2019

Presentation ARCH 2019

Minimalist TAVR: Decreasing the Length of Stay While Maintaining Quality

Presenter: Spencer J. Melby

April 11, 2019

News Conference News ACC 2019

My Takeaways From ACC 2019: Breaking With Embargoes? Despite the Drama, Embargoes Set to Stay

Shelley Wood

April 05, 2019

News Daily News

Volume Still an Important Surrogate for TAVR Quality, New Data Suggest

Todd Neale

April 03, 2019

News Daily News

First US Consensus Statement on PFO Closure Addresses Volume Requirements, Quality Measurements

Yael L. Maxwell

April 01, 2019

News Daily News

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

Michael O'Riordan

March 27, 2019

News Conference News ACC 2019

COAPT Quality-of-Life Analysis Points to Significant, Sustained Benefits in Health Status With MitraClip

Shelley Wood

March 17, 2019

News Conference News ACC 2019

COAPT Echo Substudy in HF Patients With Mitral Regurgitation Offers New Answers, and More Questions

Shelley Wood

March 17, 2019

News Daily News

FDA Extends MitraClip Indication to Include Functional MR

Shelley Wood

March 14, 2019

News Daily News

DOACs in Patients With Mitral Stenosis and A-fib: Analysis Suggests a Benefit

Todd Neale

March 12, 2019

News Conference News ACC 2019

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

Shelley Wood

March 11, 2019

News Conference News CRT 2019

BASILICA Leaflet Laceration Before TAVR Helps Prevent Coronary Obstruction

Yael L. Maxwell

March 04, 2019

Advertisement

Clip-Based Tricuspid Repair Improves Regurgitation, Function, and Quality of Life: TRILUMINATE

MR Reduction Linked to Lower HF Hospitalizations and Deaths, Regardless of Intervention: COAPT

PFO Compounds Ischemic Stroke Risk Among Patients With Pulmonary Embolism

Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer™

Public Comments Largely Supportive of CMS Plan for TAVR, With Some Suggested Tweaks

Medtronic Receives FDA Approval for World's First Quadripolar Active Fixation Left Heart Lead

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

Cardioband Reduces Severe Tricuspid Regurgitation at 6 Months, With Good Safety: TRI-REPAIR

Neovasc Announces Peer Reviewed Publication in the International Journal of Cardiology Demonstrating that the Neovasc Reducer™ Improves Diastolic Function in patients suffering from severe angina

Minimalist TAVR: Decreasing the Length of Stay While Maintaining Quality

My Takeaways From ACC 2019: Breaking With Embargoes? Despite the Drama, Embargoes Set to Stay

Volume Still an Important Surrogate for TAVR Quality, New Data Suggest

First US Consensus Statement on PFO Closure Addresses Volume Requirements, Quality Measurements

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

COAPT Quality-of-Life Analysis Points to Significant, Sustained Benefits in Health Status With MitraClip

COAPT Echo Substudy in HF Patients With Mitral Regurgitation Offers New Answers, and More Questions

FDA Extends MitraClip Indication to Include Functional MR

DOACs in Patients With Mitral Stenosis and A-fib: Analysis Suggests a Benefit

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

BASILICA Leaflet Laceration Before TAVR Helps Prevent Coronary Obstruction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content